RESEARCH
PUBLICATIONS
NEXTBIO COMMUNITY
|
|
|
-
Highly efficient asymmetric synthesis of sitagliptin.
Authors: Karl B Hansen, Yi Hsiao, Feng Xu, Nelo Rivera, Andrew Clausen, Michele Kubryk, Shane Krska, Thorsten Rosner, Bryon Simmons, Jaume Balsells,…
Journal of the American Chemical Society 2009 Jul 1 -
Inhibition of dipeptidyl peptidase IV with sitagliptin (MK0431) prolongs islet graft survival in streptozotocin-induced diabetic mice.
Authors: Su-Jin Kim, Cuilan Nian, Doris J Doudet, Christopher H S McIntosh
Diabetes 2008 May
Thought leaders and organizations working on research involving Januvia.
- Merck
- University of British Columbia
- University of Nebraska
- Sanofi-Aventis
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDD…
- Merck Research Laboratories
- University of Toronto
- University of British Columbia
- Long Island University
- Hadassah University Hospital
-
Assessment of the Effects of a DPP-4 Inhibitor (Sitagliptin) Januvia on Immune Function in Healthy Individuals
conditions: Diabetes Mellitus Type 1 ; Diabetes Mellitus Type 2
interventions: Sitagliptin (Januvia)
-
The Effect of Januvia (Sitagliptin) on Oxidative Stress in Obese Type 2 Diabetic Subjects
conditions:
interventions: Januvia (Sitagliptin) 100 mg ; Placebo
-
FDA links Januvia to pancreatitis
FiercePharma. - September 28, 2009 -
Januvia, Janumet to Note Pancreatitis Cases
WebMD. - September 25, 2009
Community
